Antimanic Treatment With Tamoxifen Affects Brain Chemistry: A Double-Blind, Placebo-Controlled Proton Magnetic Resonance Spectroscopy Study

Stork, 2005, Mitochondrial dysfunction in bipolar disorder: Evidence from magnetic resonance spectroscopy research, Mol Psychiatry, 10, 900, 10.1038/sj.mp.4001711 Leboyer, 2012, Can bipolar disorder be viewed as a multi-system inflammatory disease?, J Affect Disord, 141, 1, 10.1016/j.jad.2011.12.049 Andreazza, 2014, The neurobiology of bipolar disorder: Identifying targets for specific agents and synergies for combination treatment, Int J Neuropsychopharmacol, 17, 1039, 10.1017/S1461145713000096 Catapano, 2008, Kinases as drug targets in the treatment of bipolar disorder, Drug Discov Today, 13, 295, 10.1016/j.drudis.2008.02.007 Zanetti, 2015, Translating biomarkers and bio-molecular treatments into clinical practice: assessment of hypothesis driven clinical trial data, 149 Resin, 2015, Oxidative damage and its treatment impact, 83 Birnbaum, 2004, Protein kinase C overactivity impairs prefrontal cortical regulation of working memory, Science, 306, 882, 10.1126/science.1100021 Szabo, 2009, Glutamate receptors as targets of protein kinase C in the pathophysiology and treatment of animal models of mania, Neuropharmacology, 56, 47, 10.1016/j.neuropharm.2008.08.015 Einat, 2007, Protein kinase C inhibition by tamoxifen antagonizes manic-like behavior in rats: Implications for the development of novel therapeutics for bipolar disorder, Neuropsychobiology, 55, 123, 10.1159/000106054 Abrial, 2013, Protein kinase C regulates mood-related behaviors and adult hippocampal cell proliferation in rats, Prog Neuropsychopharmacol Biol Psychiatry, 43, 40, 10.1016/j.pnpbp.2012.11.015 Einat, 2006, Cellular plasticity cascades: Genes-to-behavior pathways in animal models of bipolar disorder, Biol Psychiatry, 59, 1160, 10.1016/j.biopsych.2005.11.004 Cechinel-Recco, 2012, Lithium and tamoxifen modulate cellular plasticity cascades in animal model of mania, J Psychopharmacol, 26, 1594, 10.1177/0269881112463124 Yildiz, 2008, Protein kinase C inhibition in the treatment of mania, Arch Gen Psychiatry, 65, 255, 10.1001/archgenpsychiatry.2007.43 Turecki, 1998, Evidence for a role of phospholipase C-gamma 1 in the pathogenesis of bipolar disorder, Mol Psychiatry, 3, 534, 10.1038/sj.mp.4000447 Baum, 2008, A genome-wide association study implicates diacylglycerol kinase eta (DGKH) and several other genes in the etiology of bipolar disorder, Mol Psychiatry, 13, 197, 10.1038/sj.mp.4002012 Wang, 1996, Enhanced protein kinase C activity and translocation in bipolar affective disorder brains, Biol Psychiatry, 40, 568, 10.1016/0006-3223(95)00611-7 Friedman, 1993, Altered platelet protein kinase C activity in bipolar affective disorder, manic episode, Biol Psychiatry, 33, 520, 10.1016/0006-3223(93)90006-Y Bebchuk, 2000, A preliminary investigation of a protein kinase C inhibitor in the treatment of acute mania, Arch Gen Psychiatry, 57, 95, 10.1001/archpsyc.57.1.95 Kulkarni, 2006, A pilot study of hormone modulation as a new treatment for mania in women with bipolar affective disorder, Psychoneuroendocrinology, 31, 543, 10.1016/j.psyneuen.2005.11.001 Zarate, 2007, Efficacy of a protein kinase C inhibitor (tamoxifen) in the treatment of acute mania: A pilot study, Bipolar Disord, 9, 561, 10.1111/j.1399-5618.2007.00530.x Clay, 2011, Mitochondrial dysfunction and pathology in bipolar disorder and schizophrenia, Int J Dev Neurosci, 29, 311, 10.1016/j.ijdevneu.2010.08.007 Cataldo, 2010, Abnormalities in mitochondrial structure in cells from patients with bipolar disorder, Am J Pathol, 177, 575, 10.2353/ajpath.2010.081068 Chang, 2014, Mitochondrial DNA variation and increased oxidative damage in euthymic patients with bipolar disorder, Psychiatry Clin Neurosci, 68, 551, 10.1111/pcn.12163 Dager, 2004, Brain metabolic alterations in medication-free patients with bipolar disorder, Arch Gen Psychiatry, 61, 450, 10.1001/archpsyc.61.5.450 Kraguljac, 2012, Neurometabolites in schizophrenia and bipolar disorder—a systematic review and meta-analysis, Psychiatry Res, 203, 111, 10.1016/j.pscychresns.2012.02.003 Frey, 2007, Abnormal cellular energy and phospholipid metabolism in the left dorsolateral prefrontal cortex of medication-free individuals with bipolar disorder: An in vivo 1H MRS study, Bipolar Disord, 9, 119, 10.1111/j.1399-5618.2007.00454.x Hamakawa, 2004, Reduced intracellular pH in the basal ganglia and whole brain measured by 31P-MRS in bipolar disorder, Psychiatry Clin Neurosci, 58, 82, 10.1111/j.1440-1819.2004.01197.x Yildiz, 2010, In vivo proton magnetic resonance spectroscopic examination of benzodiazepine action in humans, Psychiatry Res, 184, 162, 10.1016/j.pscychresns.2010.07.004 Yildiz, 2010, Combination of pharmacotherapy with electroconvulsive therapy in prevention of depressive relapse: A pilot controlled trial, J ECT, 26, 104, 10.1097/YCT.0b013e3181c189f7 Davanzo, 2001, Decreased anterior cingulate myo-inositol/creatine spectroscopy resonance with lithium treatment in children with bipolar disorder, Neuropsychopharmacology, 24, 359, 10.1016/S0893-133X(00)00207-4 Strawn, 2012, Glutamatergic effects of divalproex in adolescents with mania: A proton magnetic resonance spectroscopy study, J Am Acad Child Adolesc Psychiatry, 51, 642, 10.1016/j.jaac.2012.03.009 Schneider, 2015, Structural and functional magnetic resonance imaging findings and their treatment impact, 205 Provencher, 1993, Estimation of metabolite concentrations from localized in vivo proton NMR spectra, Magnet Reson Med, 30, 672, 10.1002/mrm.1910300604 Amrollahi, 2011, Double-blind, randomized, placebo-controlled 6-week study on the efficacy and safety of the tamoxifen adjunctive to lithium in acute bipolar mania, J Affect Disord, 129, 327, 10.1016/j.jad.2010.08.015 DelBello, 2006, Neurochemical effects of olanzapine in first-hospitalization manic adolescents: A proton magnetic resonance spectroscopy study, Neuropsychopharmacology, 31, 1264, 10.1038/sj.npp.1300950 Quiroz, 2008, Mitochondrially mediated plasticity in the pathophysiology and treatment of bipolar disorder, Neuropsychopharmacology, 33, 2551, 10.1038/sj.npp.1301671 Yuksel, 2015, Abnormal high energy phosphate molecule metabolism during regional brain activation in patients with bipolar disorder, Bipolar Disord, 17 Moretti, 2011, Tamoxifen effects on respiratory chain complexes and creatine kinase activities in an animal model of mania, Pharmacol Biochem Behav, 98, 304, 10.1016/j.pbb.2011.01.017 Steckert, 2012, Protein kinase C and oxidative stress in an animal model of mania, Curr Neurovasc Res, 9, 47, 10.2174/156720212799297056 Zarate, 2009, Protein kinase C inhibitors rationale for use and potential in the treatment of bipolar disorder, CNS Drugs, 23, 569, 10.2165/00023210-200923070-00003 Benjamin, 1963, Statistical treatment of the law of initial values (Liv) in autonomic research: A review and recommendation, Psychosom Med, 25, 556, 10.1097/00006842-196311000-00005 Yildiz, 2011, Factors modifying drug and placebo responses in randomized trials for bipolar mania, Int J Neuropsychopharmacol, 14, 863, 10.1017/S1461145710001641 Lyoo, 2002, Magnetic resonance spectroscopy: Current and future applications in psychiatric research, Biol Psychiatry, 51, 195, 10.1016/S0006-3223(01)01313-0